ArticleMolecular medicine reports2026
ΔNp63α‑mediated regulation of tumor‑associated genes and pathways in hepatocellular carcinoma progression.
Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ΔNp63α is key in cellular development and epithelial tumors; however, its role in hepatocellular carcinoma (HCC) remains unclear. In the present study, the oncogenic role and molecular functions of ΔNp63α in HCC were investigated. Analysis of The Cancer Genome Atlas revealed an association between p63 expression and patient survival. ΔNp63α overexpression in SNU387 cells notably enhanced cell proliferation and migration, supporting its role in promoting aggressive HCC phenotypes. Transcriptome analysis revealed extensive ΔNp63α‑associated transcriptional changes, with differentially expressed genes enriched in tumor‑associated processes, including 'Wnt signaling pathway', 'Notch signaling pathway', 'cell adhesion molecules' and 'extracellular matrix organization'. Chromatin immunoprecipitation sequencing revealed widespread ΔNp63α binding in promoter‑proximal and ‑distal regulatory regions, suggesting potential involvement in transcriptional regulation through both proximal and distal genomic elements. ΔNp63α upregulation was also associated with increased CCCTC‑binding factor (CTCF) occupancy near the promoters of tumor‑associated genes and these gained CTCF sites were enriched for p63 motifs. Collectively, the present findings identified ΔNp63α as an oncogenic regulator of HCC and suggest that it may regulate tumor‑associated gene programs through coordinated proximal and distal chromatin regulatory mechanisms.
Indexed as
Identifiers
42885287What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.